A fugitive who was discovered to have worked under an alias in the biotech industry has raised questions about how companies hired him despite his criminal history.
Challenges in the electrophysiology and Watchman businesses led Boston Scientific to cut its sales and earnings per share forecasts for the second quarter in a row.
Anthony Fauci, the nation's former top infectious disease expert, is scheduled to testify before Congress again tomorrow at the Senate homeland security committee.
An FDA advisory panel has narrowly voted to allow compounding pharmacies to manufacture unapproved peptides, including BPC-157 and KPV, with the recommendation of health secretary Robert F. Kennedy Jr.
A Food and Drug Administration advisory panel narrowly rejected manufacturing of the peptide emideltide but recommended allowing pharmacies to make four other peptides, including epitalon.
The U.S. health officials are investigating a new outbreak involving the diarrhea-causing parasite cyclospora, which has affected at least 72 people as of Wednesday.
The European Medicines Agency (EMA) is taking 'rapid action' to ensure that study results are made public as required by law, following a recent analysis found results for less than half of the studies registered in a key European database were reported within the required time frame.
The Senate health panel delayed until next week a vote on Erica Schwartz to run the Centers for Disease Control and Prevention, after postponing a separate vote on Sean Kaufman for a key public health preparedness role.
The Centers for Medicare and Medicaid Services (CMS) has proposed a new rule to codify limits on Medicaid provider taxes, aimed at preventing states from guaranteeing providers will be refunded for their taxes.
Novo Nordisk sued Eli Lilly for allegedly running a 'deceptive' ad campaign that uses outdated clinical trials to make its obesity and diabetes drugs appear more effective.